PXD052895 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Pharmacological and toxicological investigations of cystobactamids reveal binding and inhibition of HCV entry receptor SCARB1 |
| Description | Affinity-based protein profiling of cystobactamids in HEK293 and HeLa cells |
| HostingRepository | PRIDE |
| AnnounceDate | 2025-10-29 |
| AnnouncementXML | Submission_2025-10-29_12:10:34.766.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Timo Risch |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | iodoacetamide derivatized residue |
| Instrument | maXis |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2024-06-06 03:34:14 | ID requested | |
| ⏵ 1 | 2025-10-29 12:10:35 | announced | |
Publication List
Keyword List
| submitter keyword: SCARB1, HCV, Cystobactamid, Liver |
Contact List
| Rolf Müller |
| contact affiliation | Helmholtz-Institute for Pharmaceutical Research Saarland, Microbial Natural Products |
| contact email | rolf.mueller@helmholtz-hips.de |
| lab head | |
| Timo Risch |
| contact affiliation | Helmholtz-Institute for Pharmaceutical Research |
| contact email | timo.risch@helmholtz-hips.de |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/10/PXD052895 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD052895
- Label: PRIDE project
- Name: Pharmacological and toxicological investigations of cystobactamids reveal binding and inhibition of HCV entry receptor SCARB1